Pioneering the Future of Medicine
Ionis Pharmaceuticals is a pioneer in RNA-targeted medicine, founded in 1989 in Carlsbad, California. Over more than three decades, the company has discovered and developed six marketed medicines for serious diseases including neurological and cardiovascular conditions, with breakthrough approvals including SPINRAZA for spinal muscular atrophy and QALSODY for ALS. In 2020, Ionis transitioned to a fully integrated biotech, independently commercializing its wholly owned late-stage pipeline.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountApr 2021
May 1991
Jan 1990
Jan 1989
Create a free account to see which investors have funded this company.
Create Free Account
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Biopharmaceutical company developing sustained-release hydrogel therapies targeting retinal disea...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
